Pulmonology carries an administrative profile defined by volume and chronicity. The specialty's patient population is predominantly composed of people with long-term conditions — COPD, asthma, interstitial lung disease, pulmonary hypertension, obstructive sleep apnea — who require regular follow-up, ongoing medication authorization, and continuous care coordination with respiratory therapy, DME suppliers, and primary care. Managing that administrative infrastructure has become one of the central operational challenges in busy pulmonology practices, and virtual assistants are providing measurable relief.
The Chronic Disease Administration Challenge
The American Thoracic Society (ATS) estimates that COPD affects over 16 million Americans, with a further estimated 12 million undiagnosed cases. Add asthma (25 million), pulmonary fibrosis (estimated 100,000 prevalent cases), and pulmonary hypertension, and a pulmonology practice is managing a panel where virtually every patient requires ongoing administrative attention between visits.
This chronic disease administration includes: renewing prescriptions and coordinating prior authorization renewals for inhaled corticosteroids, long-acting bronchodilators, and specialty biologics; authorizing and coordinating home oxygen therapy and CPAP/BiPAP equipment through DME suppliers; scheduling pulmonary function tests, six-minute walk tests, and high-resolution CT imaging; and maintaining follow-up cadences for post-hospitalization COPD exacerbation patients who have a high risk of 30-day readmission.
Each of these functions is recurring, predictable, and highly amenable to VA delegation.
Biologic Authorization for Severe Asthma
The approval of biologic therapies for severe eosinophilic asthma — dupilumab (Dupixent), mepolizumab (Nucala), benralizumab (Fasenra), and tezepelumab (Tezspire) — has transformed outcomes for a subset of asthma patients but added a substantial authorization layer for practices prescribing these agents. Biologic authorizations for severe asthma require documented prior failure of high-dose inhaled corticosteroids, eosinophil count data, exacerbation history, and sometimes FeNO (fractional exhaled nitric oxide) test results.
Re-authorization cycles — typically every six to twelve months depending on the payer — require updated clinical documentation confirming ongoing response and continued clinical need. For a pulmonology practice with 50 to 100 biologic asthma patients, this represents a continuous authorization management function that VAs are well-positioned to own.
Home Oxygen and DME Coordination
Home oxygen prescription and delivery is one of the most administratively complex DME services in outpatient medicine. Medicare and commercial insurers require specific clinical criteria: documented resting SpO2 of 88% or below, or desaturation during exercise or sleep with specific qualifying test results. The initial qualifying test must be performed at the practice, the documentation must meet CMS formatting requirements, and the DME supplier must be enrolled and authorized.
When the initial oxygen prescription is approved, subsequent certificate of medical necessity renewals are required at 30-day, 60-day, and 90-day intervals in the first year, and annually thereafter. VAs trained in Medicare DME documentation requirements manage the renewal calendar, prepare CMN documentation for physician signature, and coordinate with DME suppliers to ensure uninterrupted delivery — preventing the patient care disruption that follows when a renewal lapses.
Post-Hospitalization Follow-Up to Reduce Readmissions
COPD exacerbation is one of the most common causes of hospital readmission, and CMS penalizes hospitals under the Hospital Readmissions Reduction Program for excess 30-day readmission rates. Many pulmonologists manage the outpatient follow-up function for post-exacerbation patients, scheduling visits within seven days of discharge and conducting structured telephone check-ins in the interim.
VAs handle the post-discharge outreach: contacting patients within 48 hours of discharge to confirm medication adherence, confirm follow-up appointment attendance, and flag concerning symptom changes to the clinical team. This proactive contact is associated with measurable reductions in 30-day readmission in published care management literature and provides a clear quality metric for practices participating in value-based care arrangements.
Practices managing high chronic disease volumes can benefit significantly from VA support. Stealth Agents provides medically trained VAs experienced in pulmonology administrative workflows, including DME coordination, biologic authorization, and post-discharge patient outreach.
Sources
- American Thoracic Society, "COPD Prevalence and Burden Data," Thoracic.org, 2023
- Centers for Medicare and Medicaid Services, "Home Oxygen Therapy Coverage Criteria," CMS.gov
- Centers for Medicare and Medicaid Services, "Hospital Readmissions Reduction Program," CMS.gov, 2023